The WACC of Karyopharm Therapeutics Inc (KPTI) is 6.6%.
| Range | Selected | |
| Cost of equity | 8.10% - 11.80% | 9.95% |
| Tax rate | 0.20% - 0.20% | 0.20% |
| Cost of debt | 4.00% - 7.00% | 5.50% |
| WACC | 5.0% - 8.2% | 6.6% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.91 | 1.23 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 8.10% | 11.80% |
| Tax rate | 0.20% | 0.20% |
| Debt/Equity ratio | 2.9 | 2.9 |
| Cost of debt | 4.00% | 7.00% |
| After-tax WACC | 5.0% | 8.2% |
| Selected WACC | 6.6% | |